These were the best performers on the ASX 200 in November

The Appen Ltd (ASX:APX) share price was one of the best performers on the ASX 200 in November. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite getting off to a positive start, the month of November turned out to be another disappointing one for Australian investors.

The benchmark ASX 200 finished the period with a decline of 2.8%.

But not all shares on the index finished in the red. The three best performers on the ASX 200 in November were as follows:

The Appen Ltd (ASX: APX) share price finished the month with a gain of 31%. The catalyst for this strong gain was an upgrade to its full year guidance given on November 15. Due to a sharp increase in monthly revenues from existing projects from existing customers, the developer of high-quality, human annotated datasets for machine learning and artificial intelligence lifted its full year underlying EBITDA guidance to the range of $62 million to $65 million. This compares to previous guidance of between $54 million and $59 million. Although its shares have rallied strongly, I still feel they are the best value in the WAAAX group.

The G8 Education Ltd (ASX: GEM) share price put on a gain of 36% in November. Investors have been fighting to get hold of the childcare centre operator's shares after trading conditions in the industry improved. During the month both G8 Education and one of its rivals reported improvements in key metrics such as occupancy levels. This news led to Morgan Stanley upgrading the company's shares to an overweight rating with a $3.25 price target. The broker believes that G8 Education is at an inflection point.

The Orocobre Limited (ASX: ORE) share price pushed an impressive 30% higher during the month. Improving investor sentiment in the battery materials space and a positive investor update have largely been the catalysts for Orocobre's rise this month. It was also given a boost when analysts at Citi slapped a buy rating and $6.00 price target on the company's shares at the end of October. Even after its stellar run this month, that price target implies potential upside of 39% from its current share price.

Next month I wouldn't be surprised if one of the five shares revealed below follow Orocobre's lead and push higher.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »